Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Plaudits for Bayer’s website

Ranked number two in Bowen Cragg's annual Index of Online Excellence

Bayer website 

Bayer has scored highly in a cross-industry ranking of corporate websites, coming second only to Nestlé in the results.

The company attracted praise in the Bowen Craggs Index of Online Excellence for the usability of its 'conventional' navigational and 'remarkable job of presenting itself as an exciting place to work'.

Commenting on the result Bowen Craggs said: “Bayer has been busy polishing, and with many detailed improvements has worked its way up to the second slot. It consists of a huge federation of sites and social media channels, held together with remarkable skill and allowing customers and others to get to the pages they need with little pain.”

Index of Online Excellence
1 - Nestle
2 - Bayer
3 - Eni
4 - BP
5 - GSK
5 - Novo Nordisk
5 - Roche
5 - Shell
9 - BASF
9 - Maersk
 

10th May 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics